Arizona Oncology Associates — Tempe, Arizona

Public research footprint of Arizona Oncology Associates, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Ovarian Cancer · Chronic Lymphocytic Leukemia (CLL) · Lymphoma

Recently updated registry entries

NCT03516981 — A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for… (Completed)
NCT03563716 — A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients… (Completed)
NCT04697628 — Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Arizona Oncology Associates?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.